Kory, 3,508 patient ivermectin meta analysis: 69% lower mortality [p<0.0001] https://c19p.org/kory
copied to clipboard
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
et al., FLCCC Alliance (Preprint) (meta analysis)
Meta analysis of ivermectin clinical studies and natural experiments where ivermectin has been widely used, showing efficacy of ivermectin in prophylaxis and treatment of COVID-19.There is potentially inaccurate data collection and/or reporting in some included trials.Currently there are
82 ivermectin
for COVID-19 studies, showing 53% [39‑64%] lower mortality, 31% [11‑46%] lower ventilation, 54% [36‑67%] lower ICU admission, 38% [24‑49%] lower hospitalization, and 78% [67‑86%] lower cases.
|
risk of death, 69.0% lower, RR 0.31, p < 0.001, treatment 35 of 1,551 (2.3%), control 191 of 1,957 (9.8%), NNT 13, odds ratio converted to relative risk.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Kory et al., 12/18/2020, preprint, 10 authors.
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.